We used the AIRAscore evaluation as an easily accessible approach for clinicians to firstly confirm the widespread white matter involvement as previously shown in our DTI study14 and others12,13,17 and to further delineate involved brain areas in hereditary spastic paraplegia with underlying SPAST mutations. The gene discussed is SPAST; the disease is hereditary spastic paraplegia.